Profile
ABSI NVO VRTX REGN MRNA SGEN
Company Name Absci Corporation Novo Nordisk A/S Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Moderna, Inc. Seagen Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $555.24M $563.06B $109.10B $105.53B $44.96B $43.15B
Employees 0.16K 66.02K 5.40K 13.68K 5.60K 3.26K
CEO Mr. Sean McClain Mr. Lars Fruergaard Jorgensen Dr. Reshma Kewalramani FASN, M.D. Dr. Leonard S. Schleifer M.D., Ph.D. Mr. Stephane Bancel Mr. David R. Epstein B.Sc., M.B.A.
Ratings
ABSI NVO VRTX REGN MRNA SGEN
Quant Rating Score 2 5 5 5 2 3
Quant Rating Sell Strong Buy Strong Buy Strong Buy Sell Neutral
Trading
ABSI NVO VRTX REGN MRNA SGEN
Last Close $4.91 $128.42 $422.78 $973.8 $117.31 $228.74
High 52 $6.59 $199.54 $446.08 $993.35 $137.75 $228.9
Low 52 $1.15 $87.78 $323.57 $692.45 $69.51 $187.64
Price vs. 52 Week High -25.49 % -35.64 % -5.22 % -1.97 % -14.84 % -0.07 %
Price vs. 52 Week Low 326.96 % 46.3 % 30.66 % 40.63 % 68.77 % 21.9 %
Total Return
ABSI NVO VRTX REGN MRNA SGEN
1 Month Return -19.31 % 2.41 % 5.63 % 5.81 % 9.63 % 0 %
3 Month Return 14.19 % 5.96 % -0.03 % 2.14 % 34.21 % 0 %
6 Month Return 286.61 % 26.91 % 13.15 % 21.89 % 67.47 % 7.03 %
9 Month Return 192.26 % -29.28 % 20.84 % 20.68 % 15.59 % 17.5 %
YTD Return 16.9 % 24.14 % 3.91 % 10.87 % 17.96 % 0 %
1 Year Return 295.97 % -24.01 % 20.66 % 30.61 % -8.64 % 14.66 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
ABSI NVO VRTX REGN MRNA SGEN
Dividend Yield Percentage (TTM) - 0.16 % - - - -
Dividend Paid and Capex Coverage Ration (TTM) -75.16 % 1.1 % 13.85 % 6.2 % -3.65 % -3.35 %
Dividend Per Share (TTM) - 0.2 % - - - -
Payout Ratio (TTM) - 47.03 % - - - -
Growth
ABSI NVO VRTX REGN MRNA SGEN
Asset Growth -26.96 % 30.35 % 25.23 % 13.23 % -28.74 % -1.21 %
Gross Profit Growth -13.59 % 32.32 % 9.25 % 6.49 % -85.12 % 22.93 %
Revenue Growth -0.5 % 31.26 % 10.17 % 7.76 % -64.94 % 24.65 %
Revenue 3 Year 19.91 % 90.51 % 59.87 % 55.67 % 2356.27 % 91.84 %
Revenue 5 Year 178.24 % 124.2 % 218.58 % 110.3 % 1070.62 % 215.48 %
Revenue 10 Year 178.24 % 66.11 % 608.27 % 549.62 % 6447.35 % 494.04 %
EBIT Growth 12.24 % 37.11 % -12.94 % -14.6 % -145 % 10.13 %
Net Income Growth -5.4 % 50.71 % 8.96 % -8.87 % -156.37 % 9.51 %
Net Income 3 Yeari Growth Per Share -660.74 % 106.79 % 34.59 % 13.48 % -529.9 % -764.83 %
Net Income 5 Yeari Growth Per Share -1529.65 % 133.86 % 70.33 % 74.02 % -160.17 % -276.93 %
Net Income 10 Yeari Growth Per Share -1529.65 % 98.61 % 809.6 % 871.12 % -2046.03 % -624.16 %
Operating Income Growth 12.24 % 37.11 % -12.94 % -14.6 % -145 % 10.13 %
Operating Cash Flow Growth (CFG) 20.54 % 38.06 % -14.35 % -8.39 % -162.6 % 9.07 %
Operating 3 Year CFG -490.63 % 118.29 % 9.63 % 76.95 % -253.56 % -148.34 %
Operating 5 Year CFG -974.14 % 163.51 % 174.78 % 125.17 % -100.11 % -195.86 %
Operating 10 Year CFG -974.14 % 150.92 % 5187.08 % 713.56 % -4698.89 % -2622.09 %
EPS Growth -4.35 % 52.28 % 8.33 % -8.54 % -158.15 % 10.81 %
EPS Diluted Growth -4.35 % 52.37 % 8.35 % -9.03 % -161.39 % 10.81 %
Book Value Per Share -36.62 % 29 % 25.58 % 15.03 % -25.28 % -9.83 %
Share Holder 3 Year Equity Growth Per Share 297.48 % 75.22 % 104.06 % 137.56 % 439.94 % 33.92 %
Share Holder 5 Year Equity Growth Per Share 529.07 % 121.9 % 291.14 % 219.1 % 92.24 % 220.81 %
Share Holder 10 Year Equity Growth Per Share 529.07 % 49.62 % 1030.79 % 1286.9 % 1519.81 % 691.19 %
Dividend Per Share Growth - 26.89 % - - - -
Dividend 3 Year Growth Per Share - 64.4 % - - - -
Dividend 5 Year Growth Per Share - - - - - -
Dividend 10 Year Growth Per Share - 95.44 % - - - -
Debt Growth -30.57 % 4.74 % 44.1 % 0.06 % 3.58 % -23.28 %
Free Cash Flow Growth 32.83 % 9.17 % -16.47 % -17.11 % -183.5 % 3.67 %
Updated On 31 Dec 2023 31 Dec 2023 31 Dec 2023 31 Dec 2023 31 Dec 2023 31 Dec 2022
Profitability
ABSI NVO VRTX REGN MRNA SGEN
Gross Profit Margin TTM -144.82 % 84.65 % 86.91 % 87.16 % 21.77 % 75.4 %
Return on Assets TTM -47.15 % 29.87 % 16.81 % 11.22 % -35.67 % -20.64 %
Return on Equity TTM -52.53 % 91.82 % 23.61 % 15.15 % -41.83 % -28.06 %
Return on Capital Employed TTM -56.13 % 82.5 % 21.07 % 12.53 % -35.81 % -29.5 %
Net Income Per EBT TTM 100.09 % 79.81 % 84.31 % 95.44 % 124.28 % 101.53 %
EBT Per Ebit TTM 96.04 % 101.7 % 112.45 % 104.74 % 93.44 % 93.47 %
EBIT Per Revenue TTM -2011.46 % 45.03 % 41.62 % 29.46 % -99.69 % -34.37 %
Cash Flow To Debt Ratio TTM -631.33 % 346.88 % 546.79 % 238.94 % -232.98 % -475.96 %
Receivables Turnover TTM 2.61 3.87 5.68 2.51 13.32 3.64
Payables Turnover TTM 9.31 2.88 0.42 2.51 22.04 2.52
Inventory Turnover TTM - 1.12 1.64 0.62 13.67 1.07
Fixed Asset Turnover TTM 12.48 % 248.64 % 685.54 % 310.02 % 186.78 % 471.71 %
Asset Turnover TTM 2.44 % 81.71 % 42.58 % 38.12 % 30.81 % 63.3 %
Operating Cash Flow Per Share TTM -0.7 20.95 15.27 43.96 -7.54 -2.87
Free Cash Flow Per Share TTM -0.71 11.28 14.17 36.87 -9.61 -3.73
Cash Per Share TTM 122.99 % 208.61 % 3939.31 % 9758.35 % 2235.6 % 657.5 %
Operating Cash Flow Sales Ratio TTM -1130.4 % 38.24 % 38.72 % 36.17 % -55.91 % -23.48 %
Free Cash Flow Operating Cash Flow Ratio TTM 101.33 % 53.85 % 92.78 % 83.87 % 127.41 % 129.82 %
Cash Flow Coverage Ratios TTM -631.33 % 346.88 % 546.79 % 238.94 % -232.98 % -475.96 %
Price To Free Cash Flows Ratio TTM -8.48 77.52 29.81 26.55 -12.24 -61.54
Price To Operating Cash Flows Ratio TTM -7.03 42.47 27.68 22.15 -15.55 -79.67
Price Cash Flow Ratio TTM -7.03 42.47 27.68 22.15 -15.55 -79.67
Income Statement (TTM)
ABSI NVO VRTX REGN MRNA SGEN
Revenue $0.01B $232.26B $9.84B $13.12B $6.75B $1.96B
Gross Profit $-0.01B $196.5B $8.58B $11.3B $2.06B $1.55B
Gross Profit Ratio -144.82% 84.6% 87.17% 86.16% 30.52% 79.1%
EBITDA $-0.08B $112.94B $3.93B $5.13B $-3.21B $-0.62B
Net Income $-0.11B $83.68B $3.62B $3.95B $-4.71B $-0.61B
EPS Diluted -1.2 18.62 13.89 34.77 -12.34 -3.3
Balance Sheet (MRQ)
ABSI NVO VRTX REGN MRNA SGEN
Long Term Debt $0B $20.53B $0.72B $2.7B $1.22B $0.04B
Total Liabilities $0.06B $207.93B $5.15B $7.11B $4.57B $0.87B
Total Equity $0.18B $106.56B $17.58B $25.97B $13.85B $2.8B
Total Investments $0.03B $17.5B $3.45B $13.51B $4.68B $1.42B
Total Debt $0.02B $27.01B $0.81B $2.7B $1.24B $0.04B
Total Assets $0.23B $314.49B $22.73B $33.08B $18.43B $3.67B
Cash Flow Statement (TTM)
ABSI NVO VRTX REGN MRNA SGEN
Net Income $-0.11B $83.68B $3.62B $3.95B $-4.71B $-0.61B
Inventory $0B $-7.42B $-0.32B $-0.27B $0.75B $-0.23B
Dividends Paid $0B $-31.77B $0B $0B $0B $0B
Operating Cash Flow $-0.06B $108.91B $3.54B $4.59B $-3.12B $-0.45B
Capital Expenditure $-0B $-38.9B $-0.26B $-0.93B $-0.71B $-0.08B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 1.78
ABCL AbCellera Biologics Inc. 3.83
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 4.2
ABIO ARCA biopharma, Inc. 3.47
ABOS Acumen Pharmaceuticals, Inc. 3.36
ABUS Arbutus Biopharma Corporation 2.88
ABVC ABVC BioPharma, Inc. 1.06
ABVX Abivax SA American Depositary Shares 14.09
ACAD ACADIA Pharmaceuticals Inc. 15.25
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 1.47
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 0.9401
ACHV Achieve Life Sciences, Inc. 4.61
ACIU AC Immune SA 2.31
ACLX Arcellx, Inc. 49.74
ACRV Acrivon Therapeutics, Inc. Common Stock 8.77
ACST Acasti Pharma Inc. 2.76
ACXP Acurx Pharmaceuticals, Inc. 2.03
ETFs With Exposure to ABSI
Ticker ETF Name Weight Percentage Price
IWM iShares Russell 2000 ETF 0.00364 204.29
VTI Vanguard Total Stock Market Index Fund 0 258.05
IBB iShares Biotechnology ETF 0.01801 133.4
SCHB Schwab U.S. Broad Market ETF 0.0005921 60.61
ITOT iShares Core S&P Total U.S. Stock Market ETF 0.0011 114.52
SCHA Schwab U.S. Small-Cap ETF 0.00940805 48.03
IWN iShares Russell 2000 Value ETF 0.00759 156.19
VBK Vanguard Small Cap Growth Index Fund 0.01 251.38
BIB ProShares Ultra Nasdaq Biotechnology 0.00789058 54.47
VXF Vanguard Extended Market Index Fund 0 170.59
HDG ProShares Hedge Replication ETF 0.000589852 49.2889
UWM ProShares Ultra Russell2000 0.00130458 38.06
ARKG ARK Genomic Revolution ETF 1.15 24.9
IWC iShares Micro-Cap ETF 0.07298 117.111
TILT FlexShares Morningstar US Market Factors Tilt Index Fund 0 195.96
URTY ProShares UltraPro Russell2000 0.000958145 45.05
BTEC Principal Healthcare Innovators ETF 0.05 35.6542
ISCB iShares Morningstar Small-Cap ETF 0 54.62
ISCG iShares Morningstar Small-Cap Growth ETF 0.01 45.55
VTWG Vanguard Russell 2000 Growth Index Fund 0.01 189.17
VITNX Vanguard Institutional Total Stock Market Index Fund Institutional Shares 0 89.47
VITPX Vanguard Institutional Total Stock Market Index Fund Institutional Plus Shares 0 89.45
VBAIX Vanguard Balanced Index Fund Institutional Shares 0 46.27
VBIAX Vanguard Balanced Index Fund Admiral Shares 0 46.27
VBINX Vanguard Balanced Index Fund Investor Shares 0 46.27
RYLD Global X Russell 2000 Covered Call ETF 0 16.53
DFAU Dimensional US Core Equity Market ETF 0.000201 36.29
IBBQ Invesco Nasdaq Biotechnology ETF 0.025 21.69
DFUS Dimensional U.S. Equity ETF 0.00006072 56.68
DFAT Dimensional U.S. Targeted Value ETF 0.00044741 53.58
2B70.DE iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) 0.01383 5.828
VTSAX Vanguard Total Stock Market Index Fund 0 125.62
NTKI Nationwide Russell 2000 Risk-Managed Income ETF 0 19.0104
BTEC.L iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) 0.02274 6.2875
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0 129.48
VITSX Vanguard Total Stock Market Index Fund 0 125.64
WDNA WisdomTree BioRevolution Fund 0.0034219 16.07
BTEE.L iShares Nasdaq US Biotechnology UCITS ETF 0.02274 6.308
AGED.L iShares Ageing Population UCITS ETF 0.03 7.165
DFSU Dimensional US Sustainability Core 1 ETF 0 33.87
SWTSX Schwab Total Stock Market Index Fd Select Shs a Series of Schwab Capit 0.000570412 88.42
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0 129.49
VSGAX Vanguard Small-Cap Growth Index Fd Admiral 0.01 88.35
2B77.DE iShares Ageing Population UCITS ETF 0.01667 6.654
DRDR.L iShares Healthcare Innovation UCITS ETF 0.04 597.375
2B78.DE iShares Healthcare Innovation UCITS ETF 0.02269 6.941
VEMPX Vanguard Extended Market Index InstlPlus 0 319.54
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0 235.66
Unlock